BrosMed Announces CE Mark and Launch of Conger™ Hydrophilic Coated Wire
Release time:
2016-03-13
BrosMed Announces CE Mark and Launch of Conger™ Hydrophilic Coated Wire
BrosMed Announces CE Mark and Launch of Conger™ Hydrophilic Coated Wire
March 15, 2016—BrosMed announced the CE Mark and launch of its Conger™ Hydrophilic Coated Wire for peripheral vasculature during diagnostic and interventional procedures.
The Conger™ Hydrophilic Guidewire is constructed from a high-quality, steerable metallic alloy core wire with a polymer coating, utilizing a sophisticated construction process to improve the crossability of the guidewire. The hydrophilic coating is applied over the radiopaque polymer jacket to reduce friction.
As part of the BrosMed Medical product portfolio, the Conger™ Hydrophilic Coated Wire will definitely enhance the company’s market penetration along with existing products such as Artimes™ PTCA, Apollo™ PTCA, Minerva™ 0.018 PTA, Achilles™ NC 0.018 PTA, Polux™ 0.014 PTA, Castor™ NC 0.014, Atropos™ 0.035, Hermes™ NC 0.035 PTA and a series of accessories.
“The wide range of the Conger™ Hydrophilic Coated Wire, from 45cm to 260cm in length and with diameters from 0.025” to 0.038”, will cover most clinical needs, and we believe the launch of Conger™ Wire will enhance the BrosMed brand in the market and keep us competitive with others,” said Jos A.W.J de Korte, General Manager of BrosMed Medical B.V., the Netherlands, the marketing and sales center of BrosMed Medical in Europe.
Please contact our regional distributors and/or our sales team at sales@brosmed.com or cs@brosmed.eu, or call our office at +31 850 14 09 01 for more product details.
About BrosMed Medical
BrosMed Medical is more than just a company; we are leading the medical device design and manufacturing revolution.
BrosMed Medical develops, manufactures and markets medical devices primarily used by interventional cardiologists, radiologists and vascular surgeons in angioplasty procedures and other minimal invasive devices.
We provide solutions to our customers through innovative design, effective supply chain management, world-class manufacturing, and flexible channels of distribution and through the development or acquisition of innovative technologies.
Join Us!
Please fill out this form and we will get in touch within 24 hours.
* Note: Please be sure to fill in the information accurately and keep the communication unblocked. We will get in touch with you as soon as possible.
More news
BrosMed Announces Canadian Approval of RevoEdge™ High-Pressure Cutting Balloon
BrosMed Medical today announced Canadian regulatory approval of the RevoEdge™ High-Pressure Cutting Balloon Dilatation Catheter, expanding the company’s presence in North America and marking another milestone in the global commercialization of its specialty coronary portfolio.
2026-09-14
BrosMed Announced CE MDR Approval of VascuGlide™ Microcatheter System
June 15, 2026-BrosMed is pleased to announce that the VascuGlide™ Microcatheter System has received CE MDR certification, marking another significant milestone in the company's commitment to advancing peripheral intervention solutions.
2026-06-18
